Researchers found that apple peels from local and commercial varieties are rich in phenolic compounds with antioxidant and ...

Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells ...

Primary endpoints of both Advance-HTN and Launch-HTN studies, using lorundrostat to treat patients with hypertension were met ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and resistant hypertension.

Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...

So as way of background, EZH2 is an epigenetic enzyme that's overexpressed in castrate-resistant prostate cancer, and it's ...

A discovery led by OHSU was made possible by years of study conducted by University of Portland undergraduates. Scientists ...

patients with high levels of this enzyme had a better prognosis, an effect that was even more pronounced in those treated with a particular type of immunotherapy, the immune checkpoint inhibitors ...